Strategic Asset Leasing, Inc.

$0.00+50.00%(+$0.00)
TickerSpark Score
44/100
Weak
73
Valuation
20
Profitability
60
Growth
36
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LEAS research report →

52-Week Range2% of range
Low $0.00
Current $0.00
High $0.01

Companywww.anewmeds.com

Anew Medical, Inc. focuses on developing biologic medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is based in Omaha, Nebraska.

CEO
Joseph Sinkule
IPO
1988
Employees
1
HQ
Omaha, NE, US

Price Chart

-40.00% · this period
$0.01$0.00$0.00May 10Nov 08Jun 13

Valuation

Market Cap
$211.46K
P/E
-0.52
P/S
0.00
P/B
0.27
EV/EBITDA
-2.58
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-54.28%
ROIC
-22.73%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-598,593 · 46.03%
EPS
$-0.00 · 90.77%
Op Income
$-574,370
FCF YoY
-155.26%

Performance & Tape

52W High
$0.01
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
0.61
Avg Volume
4.11M

Get TickerSpark's AI analysis on LEAS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our LEAS Coverage

We haven't published any research on LEAS yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate LEAS Report →

Similar Companies